IMAP has advised GenoData EDV-Systeme GmbH, a provider of data/ process management, and business intelligence for the banking and finance sector, on its acquisition by FOCONIS AG, a portfolio company of Main Capital Partners. GenoData and FOCONIS are a natural fit due to their complementary products, customers and strategy. Together with GenoData, FOCONIS intends to become a leading software provider for data management and BI solutions for banks and other financial service providers.
GenoData, founded in 1992 and headquartered in Landau (Rheinland Pfalz), is a medium-sized software and IT service company for financial institutions, mainly from the cooperative banking sector in Germany. The company maintains a modularly designed product range around data and process management as well as business intelligence. The company’s customers benefit from the tried and tested modular system GDix for data management, networking and interpretation. A decisive advantage lies in the close coordination between the data supply and the interfaces to the core banking application.
FOCONIS AG is a leading provider of data quality, control and compliance software, supporting financial institutions with internal reporting and compliance with legal requirements. The solutions are focused on banks in German-speaking countries and currently have more than 600 customers.
Katharina Lederle, former CEO and shareholder of GenoData GmbH, is very satisfied with the transaction: “In FOCONIS, we have found the right partner for the future; not only for our products, but also for our employees and customers. I am pleased to hand over the entire leadership to Bernd Frese. I would also like to express my special thanks for the support provided by IMAP, which was outstanding both professionally and personally around the clock. A deep understanding of the market paired with a strong M&A expertise helped a lot to lead the negotiations to success.”
The IMAP team around Dr. Carsten Lehmann, Lennart Hunold und Björn Voll exclusively advised Mrs. Lederle in a structured M&A process through all phases until the successful closing.